Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing three shoulder nerve blocks for pain relief and breathing effects

Official title: Analgesic Efficacy and Respiratory Effects of Interscalene, Anterior Suprascapular, and Pericapsular Nerve Group Blocks in Shoulder Arthroscopy

Run by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · NCT07429669 · Data updated 2026-11-12

This study tests three different nerve blocks to see which best controls pain while preserving breathing after arthroscopic shoulder surgery.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment120 (estimated)
SponsorAtatürk Chest Diseases and Chest Surgery Training and Research Hospital
Academic / other
Locations1 site (Yenimahalle, Ankara)
StatusRecruiting
StartedFebruary 23, 2026
Main results expectedNovember 10, 2026
Study endsNovember 30, 2026
Registry record updatedFebruary 24, 2026
Trial IDNCT07429669 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective arthroscopic shoulder surgery with ASA I–III who can give written consent and have no contraindications to regional anesthesia are ideal candidates.

Probably not a fit

Patients with contralateral phrenic nerve palsy, serious pulmonary disease, severe coagulopathy, infection at the block site, known allergy to local anesthetics, chronic opioid use, or neuropathic pain are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares interscalene block, anterior suprascapular block, and a pericapsular nerve group (PENG) block in patients having elective arthroscopic shoulder surgery. Participants will receive one of the three regional anesthesia techniques and have postoperative pain and respiratory function, including diaphragmatic performance, monitored. The comparison aims to identify techniques that provide adequate analgesia without the phrenic nerve blockade and diaphragmatic dysfunction seen with interscalene blocks. The study is being conducted at Ankara Etlik City Hospital and enrolls adult surgical patients with ASA I–III who give informed consent.

Why it matters

Potential benefit: If successful, the findings could identify a nerve block approach that gives good postoperative pain relief with fewer breathing problems.

How similar studies have gone: Interscalene block is an established gold standard but is linked to diaphragmatic dysfunction, while some studies show anterior suprascapular blocks can provide sufficient analgesia and the shoulder PENG approach is a newer, less-tested alternative.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with ASA scores I-II-III
* Patients scheduled for elective arthroscopic shoulder surgery
* Patients who have been informed about the study and have given written consent will be included.

Exclusion Criteria:

* Those with a known allergy to local anesthetics
* Those with an infection at the application site
* Those with a severe coagulopathy disorder or anticoagulant use
* Those with contralateral phrenic nerve palsy or a serious pulmonary diagnosis
* Those with a history of chronic opioid use or neuropathic pain

Where it's running

  • Ankara Etlik City Hospital
    Yenimahalle, Ankara, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.